Latest Muscarinic antagonists Stories
STIOLTO RESPIMAT is the only COPD treatment that includes two proven agents: tiotropium, the active ingredient in SPIRIVA®, and olodaterol RIDGEFIELD, Conn., May 26, 2015 /PRNewswire/ -- Boehringer
New data analyses further examine efficacy and safety across all GOLD categories, as well as COPD patients beginning or already on a maintenance therapy, including inhaled corticosteroids (ICS) DENVER,
Data Presented in Plenary Session at AUA 2015 TOKYO and NEW ORLEANS, May 17, 2015 /PRNewswire/ -- Astellas Pharma Inc.
- Divestiture permits Actavis to enhance focus on core strategic therapeutic categories - DUBLIN, Feb.
New choice between mist and dry powder inhalers for tiotropium RIDGEFIELD, Conn., Jan. 21, 2015 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc.
RIDGEFIELD, Conn., Nov. 3, 2014 /PRNewswire/ -- Boehringer Ingelheim today announced that the U.S.
Data for the co-administration of Spiriva® HandiHaler® (tiotropium bromide inhalation powder) + Striverdi® Respimat® (olodaterol) Inhalation Spray presented at CHEST 2014 RIDGEFIELD,
Approval Marks New Inhaler Choice for tiotropium RIDGEFIELD, Conn., Sept. 25, 2014 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. announced today that the U.S.
GENEVA, September 15, 2014 /PRNewswire/ -- Following the decision by the principal European manufacturers to exit or end market development and regulatory support for the
Additionally, data from the WISDOM trial on stepwise withdrawal of ICS in COPD was also presented at ERS and simultaneously published in the New England Journal of Medicine RIDGEFIELD,
- Stoppage; cessation (of labor).
- A standing still or idling (of mills, factories, etc.).